SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-066499
Filing Date
2019-03-07
Accepted
2019-03-07 09:00:32
Documents
7
Period of Report
2019-03-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d721001d8k.htm 8-K 18935
2 EX-1.1 d721001dex11.htm EX-1.1 189960
3 EX-5.1 d721001dex51.htm EX-5.1 6902
4 EX-99.1 d721001dex991.htm EX-99.1 7314
5 EX-99.2 d721001dex992.htm EX-99.2 7341
6 GRAPHIC g721001g0306115255136.jpg GRAPHIC 2588
7 GRAPHIC g721001g0306125035165.jpg GRAPHIC 3022
  Complete submission text file 0001193125-19-066499.txt   239959
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 19664437
SIC: 2834 Pharmaceutical Preparations